230
ANSWER 77
The outcome for a baby destined to be born prematurely can be improved by the admin-
istration of corticosteroids to the mother, preferably at least 48 hours before delivery.
This increases surfactant production by the fetus, reduces the risk and the severity of the
respiratory distress syndrome, increases survival and reduces other morbidities. When
there has been prolonged rupture of membranes, administration of antibiotics to the
mother reduces the risk of sepsis in the newborn. Where possible, delivery should be
planned so that the neonatal team and their equipment are fully prepared and experi-
enced members of staff are available. The parents should be counselled about what to
expect and the outcomes for a baby born prematurely. The importance of expressing
breast milk as soon as possible after delivery should be emphasized.
At delivery, the immediate management priorities for a premature baby are similar to
those for any other baby. However, heat loss will be greater, as they are smaller, the
lungs are stiffer due to surfactant deficiency and are more fragile, and the premature
baby will have fewer metabolic reserves. The baby should be dried and covered, or placed
in a plastic bag under a radiant heater. The baby should be assessed for breathing, heart
rate, colour and tone, and the airway positioned optimally. The baby will need respira-
tory support, which may be non-invasive continuous positive airways pressure (CPAP),
or intubation. Surfactant may need to be administered in the delivery room. Excessive
positive pressure ventilation (which may cause a pneumothorax) and hyperoxia should
be avoided. The baby should then be transferred promptly to the neonatal unit.
The chest radiograph shows airspace shadowing consistent with respiratory distress
syndrome (RDS, also known as hyaline membrane disease or surfactant deficiency dis-
ease). Surfactant is produced by type II pneumocytes and its production by the fetus
increases towards term. Deficiency of surfactant results in poorly compliant, low-
volume lungs, with ventilation–perfusion mismatching. Although surfactant production
will increase after delivery, this can be impaired by acidosis, hypoxia and hypothermia.
Clinical features include grunting, tachypnoea, chest recession and cyanosis. Exogenous
surfactant can be administered via an endotracheal tube and can be given electively to
very premature babies, who are very likely to develop RDS, or as rescue treatment when
RDS becomes apparent.
!Complications of premature birth
• Respiratory – RDS, pneumothorax, apnoea, chronic lung disease
• Cardiovascular – patent ductus arteriosus
• Neurological – periventricular haemorrhage, periventricular leucomalacia
• Gastrointestinal – necrotizing enterocolitis, gastro-oesophageal reflux
• Infection – group B Streptococcus, nosocomial infection
• Metabolic – hypoglycaemia, jaundice, rickets
• Iatrogenic – extravasation injury, pressure sores
KEY POINTS
• Antenatal corticosteroids improve the outcome of premature infants.
• Respiratory distress syndrome is common in premature babies.
• Endotracheal administration of surfactant is used to treat respiratory distress
syndrome.
100 Cases in Paediatrics